Abstract:Objective To enhance the understanding of fulminant type 1 diabetes (FT1 DM). Methods Clinical and laboratory data of 3 patients diagnosed as FT1 DM in our hospital from January 2007 to March 2008 were retrospectively analyzed. Results (1) All of 3 cases were males aged from 29 to 43 years old with body mass index ranged from 21.5 to 23.3 kg/m2. (2)They were developed to ketoacidosis rapidly after the appearance of diabetic symptoms in 2-4 days. One case had a cardiac arrest. (3) At the stage of onset, the plasma glucose level were above 38 mmol/L, glycosylated hemoglobin ranged from 6.2% to 6.3% and serum glycated albumin ranged from 15% to 24%. (4) Serum glutamic acid deearboxylase antibody and protein tyrosine phosphatase antibody were negative. (5) Their β-cell functions were extremely poor confirmed by a standard test meal and arginine stimulation test. (6) Serum hemodiastase (263-2319 U/L) and lipase (812-859 U/L) were high. Ultrasound and computed tomography showed a normal pancreas. (7) Serum creatinekinase level (1283-12 239 U/L) was extremely high. One case had rhabdomyolysis confirmed by biopsy at gastrocnemius muscle. Serum liver enzyme and myocardial enzyme pedigree were risen significantly. (8) Case 1 was treated with multiple daily insulin injections (MDI) when he was discharged. Case 2 was treated with continuous subcutaneous insulin infusion (CSII). Case 3 was treated with MDI at the beginning of the therapy and transferred to CSII later. Comparing glycemic parameters of continuous glucose monitoring, not only mean level of 24 h blood glucose and intra-day giycemic variability (mean amplitude of giycemic excursions and Schlichtkrull's M-value) but also day-to-day glycemic variability (absolute means of daily differences) were indicated case 2 < case 3 (CSII) < case 1 < case 3 (MDI). Conclusions (1) FT1 DM patients had clinical feathers of abrupt onset, serious metabolic disorders, serious impaired islet β-cell function, complicated with multiple organ impair, which required special attention by all medical practitioners. (2) FTI DM patients had a great glycaemia excursion and were subject to hypoglycaemia. Maybe long-term CSII regimen was needed to improve the prognosis.

Sudden Death of a 15-Year-old Girl Due to Fulminant Type 1 Diabetes Mellitus—diabetic Ketoacidosis Induced Cerebral Edema?

MON-107 Diabetic Ketoacidosis at Type 1 Diabetes Diagnosis in Children from a Large Centre (hangzhou, China)

[Sudden death from hypoglycemia]

Electron Microscopy Revealed Massive Lipid Droplets in Cardiomyocytes in a Patient with Cardiogenic Shock Following a Fulminant Type 1 Diabetes Mellitus

Changes of blood electrolytes and lipids in type 1 diabetes mellitus children with ketoacidosis (DKA)

Prominent black esophagus, Wischnewsky spots, and black duodenum in a fatal hypothermia case with an underlying diabetic ketoacidosis

A histopathologically diagnosed case of hypoglycemic encephalopathy due to insulin overdose

Autonomic and sensory ganglionopathy occurring in a patient with fulminant type 1 diabetes mellitus

Fourier-transform Infrared Microspectroscopy of Pulmonary Edema Fluid for Postmortem Diagnosis of Diabetic Ketoacidosis.

Serum Metabolic Signatures of Fulminant Type 1 Diabetes.

From neglect to peril: diabetic ketoacidosis unleashing colonic necrosis and perforation in an adolescent girl with type 1 diabetes mellitus

Analysis on the Cause of Death in 330 Cases with Type 2 Diabetes

Stevens-Johnson Syndrome/Toxic epidermal necrolysis complicated with fulminant type 1 diabetes mellitus: a case report and literature review

Diabetes ketoacidosis and Recurrent Childhood Stroke-like Episodes

FTIR Microspectroscopy of Renal Tubules for the Identification of Diabetic Ketoacidosis Death

An Unusual Presentation of Fatal Acute Haemorrhagic Pancreatitis in a Young Adult

Case Report: A Sudden Thyroid-Related Death of a 15-Year-Old Girl

Fulminant Type 1 Diabetes in China： a Case Report and Review of the Literature

Approach to the patient with fulminant type 1 diabetes

Fulminant Type 1 Diabetes:The Clinical Features and Treatment Strategy

Pancreatogenic diabetes presenting with diabetic ketoacidosis: A rare manifestation of chronic pancreatitis